Top 50 Medical VC Funds & Investors in France (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
53 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $713k–$35M |
|
Kurma Partners
VC Fund
|
16 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Karista
VC Fund
|
13 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $713k–$43M |
|
Sofinnova Partners
VC Fund
|
12 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
Idinvest Partners
VC Fund
|
12 | France, United States, Spain | Series B, Series A | Biotechnology, Health Care, Software | $3.3M–$66M |
|
GO CAPITAL
VC Fund
|
11 | France, Canada, Israel | Seed, Series A | Biotechnology, Software, Health Care | $516k–$13M |
|
Sofimac Investment Managers
VC Fund
|
8 | France, Italy, Austria | Seed, Series A | Biotechnology, Health Care, Manufacturing | $274k–$15M |
|
Angels Santé
VC Fund
|
8 | France, India, United States | Seed, Angel | Health Care, Biotechnology, Medical Device | $658k–$4.2M |
|
Octalfa
VC Fund
|
8 | France | Seed, Series A | Biotechnology, Health Care, Medical | $658k–$4.6M |
|
Seventure Partners
VC Fund
|
8 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.1M–$65M |
|
XAnge
VC Fund
|
7 | France, Germany, Belgium | Series A, Seed, Series B | Software, SaaS, E-Commerce | $1.1M–$60M |
|
KREAXI
VC Fund
|
7 | France, Italy, Switzerland | Seed, Series A | Software, SaaS, Health Care | $27k–$15M |
|
Auriga Partners
VC Fund
|
7 | France, United States, Switzerland | Series B, Series A | Biotechnology, Health Care, Medical | $2.2M–$33M |
|
LBO France
VC Fund
|
7 | France, Spain, Germany | Series A, Series B | Health Care, Medical, Software | $3.3M–$191M |
|
Crédit Agricole
VC Fund
|
6 | France, United States, Italy | Debt Financing, Seed | Energy, Health Care, Software | $768k–$1.3B |
|
MACSF
VC Fund
|
6 | France, Spain, Ecuador | Series A, Seed | Health Care, Medical, Medical Device | $1.1M–$44M |
|
M Capital Partners
VC Fund
|
6 | France, United States, Canada | Seed, Series A | Health Care, Software, Food and Beverage | $1.1M–$7.7M |
|
IRDI SORIDEC Gestion
VC Fund
|
6 | France, Brazil, Singapore | Seed, Series A | Software, Biotechnology, Medical | $1.6M–$13M |
|
BNP Paribas Développement
VC Fund
|
6 | France, Germany, The Netherlands | Series A, Seed | Software, Health Care, Information Technology | $2M–$25M |
|
Sham Innovation Santé
VC Fund
|
5 | France | Series B, Series A | Biotechnology, Medical Device, Medical | $5.7M–$80M |
|
Elaia
VC Fund
|
5 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
Isai
VC Fund
|
5 | France, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Internet | $878k–$50M |
|
ODYSSEE VENTURE
VC Fund
|
5 | France, United States | Series A, Private Equity | Software, Information Technology, Analytics | $1.6M–$11M |
|
Extens
VC Fund
|
4 | France | Private Equity | Medical, Health Care, Apps | |
|
Finovam Gestion
VC Fund
|
4 | France, United States | Seed, Series A | Software, Information Technology, Medical | $505k–$12M |
|
Kima Ventures
VC Fund
|
4 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $549k–$16M |
|
Cap Innov'Est
VC Fund
|
4 | France, United States | Seed, Series A | Biotechnology, Medical, Health Care | $549k–$7.7M |
|
Kerala Ventures
VC Fund
|
4 | France | Seed, Series A | SaaS, Rental, Internet | $329k–$11M |
|
Région Sud Investissement
VC Fund
|
4 | France, Spain | Seed, Series A | Software, Information Technology, Manufacturing | $1.1M–$22M |
|
IRDI
VC Fund
|
4 | France | Series A, Seed | Health Care, Software, Biotechnology | $1.6M–$22M |
|
Banque des Territoires
VC Fund
|
4 | France, United States | Seed, Series A | Software, Information Technology, Health Care | $1.4M–$31M |
|
Innovacom
VC Fund
|
4 | France, United States, Canada | Series A, Series B | Software, Mobile, Telecommunications | $2.4M–$58M |
|
Nord France Amorcage
VC Fund
|
4 | France, United States | Seed, Series A | Software, Information Technology, Medical | $329k–$25M |
|
Crédit Mutuel Innovation
VC Fund
|
4 | France, United States, Canada | Series A, Series B | Software, Health Care, Biotechnology | $3.3M–$43M |
|
Pays de la Loire Participations
VC Fund
|
4 | France | Seed, Private Equity | Manufacturing, Software, Information Technology | $341k–$2.5M |
|
iBionext
VC Fund
|
4 | France | Series A, Series B | Medical Device, Artificial Intelligence, Drones | $7.7M–$39M |
|
Turenne Capital
VC Fund
|
3 | France, Poland, Germany | Series A, Private Equity | Software, Biotechnology, Medical | $2.8M–$22M |
|
Sambrinvest
VC Fund
|
3 | Belgium, France, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | |
|
Bpifrance Digital Venture
VC Fund
|
3 | France, India | Seed, Series A, Pre-Seed | Health Care, SaaS, Software | $439k–$17M |
|
Ventech
VC Fund
|
3 | France, Germany, United States | Series A, Series B, Seed | Software, E-Commerce, Internet | $1.2M–$69M |
|
Newfund
VC Fund
|
3 | France, United States, Canada | Seed, Series A | Software, Information Technology, SaaS | |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Galia Gestion
VC Fund
|
3 | France, United States | Series A, Seed | Software, Manufacturing, Biotechnology | $531k–$6.9M |
|
IXO Private Equity
VC Fund
|
3 | France, United States, Canada | Private Equity, Series A | Health Care, Manufacturing, Biotechnology | $2.2M–$22M |
|
Rhone-Alpes Creation
VC Fund
|
3 | France | Seed, Series A | Environmental Engineering, Mobile, Medical | $878k–$4.4M |
|
Omnes Capital
VC Fund
|
3 | France, Germany, United States | Series A, Series B | Software, Biotechnology, Health Care | $3.5M–$44M |
|
Supernova Invest
VC Fund
|
3 | France, Switzerland, United States | Series A, Series B | Manufacturing, Health Care, Medical Device | $6M–$65M |
|
WiSEED
VC Fund
|
3 | France, Norway | Seed, Equity Crowdfunding | Software, Biotechnology, Manufacturing | $384k–$3.3M |
|
CEA Investissement
VC Fund
|
3 | France, Canada, United States | Seed, Series A | Manufacturing, Biotechnology, Semiconductor | $796k–$21M |
|
Serena
VC Fund
|
3 | France, United States, Switzerland | Series A, Seed, Series B | Software, Artificial Intelligence, Internet | $1.4M–$55M |
| Access all 556 VC funds in France Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1072
- Round size: Seed $713k–$6.9M; Series A $2.6M–$35M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
- Igyxos — Igyxos Biotherapeutics is harnessing breakthrough science in monoclonal antibodies to pioneer novel therapeutics that aim to transform the treatment of infertility in men and women.
- Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 132
- Round size: Seed $2.3M–$13M; Series A $3.8M–$95M; Series B $8.8M–$80M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 147
- Round size: Seed $713k–$6.6M; Series A $1.2M–$18M; Series B $2.5M–$43M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
- Physikron — Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A
- Geography: France, United States, Spain
Investor stats
- Total investments: 252
- Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
- Glovo — Glovo delivers the best products of your city in less than 1 hour
- Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 135
- Round size: Seed $516k–$5.5M; Series A $2.1M–$13M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
- AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: France, Italy, Austria
Investor stats
- Total investments: 73
- Round size: Seed $274k–$2M; Series A $1.6M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 37
- Round size: Seed $1.1M–$4.2M; Angel $658k–$1.3M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
- Odimma — Empowering personalized immunotherapy to treat cancer
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
Octalfa is a France-based venture capital firm that offers a range of financial services.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 20
- Round size: Seed $658k–$4.6M; Series A $1.5M–$3.7M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.
- Ventuno Biotech — Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 218
- Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 213
- Round size: Seed $1.1M–$8M; Series A $3M–$20M; Series B $6M–$60M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $234M in 2021
Portfolio highlights
- ELDIM —
- Dattak — Dattak offers cyber insurance solutions based on cybersecurity technologies. Their cybersecurity tools allow us to assess a company's level of cybersecurity without complex questionnaires. They provide their policyholders with a variety of cybersecurity tools to help them prevent and defend against cyberattacks.
- Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
Kreaxi is a management company specializing for over 30 years in investing in the capital of innovative and technological startups with high potential.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A
- Geography: France, Italy, Switzerland
Investor stats
- Total investments: 63
- Round size: Seed $27k–$3.8M; Series A $1.5M–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $28M in 2018
Portfolio highlights
- QiOVA — QiOVA develops and markets the world's fastest laser marking and micromachining solutions for serialization and traceability market.
- Primo1D — Discover Primo1D's smart RFID threads for sustainable textile traceability, boosting visibility, inventory accuracy & circularity across sectors.
- Ciliatech — Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects.
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 128
- Round size: Series A $2.2M–$14M; Series B $3.8M–$33M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Amplitude — Amplitude is a leading manufacturer of femtosecond lasers. We are laying the foundations for advances in science, industry, and health care.
- Pherecydes Pharma — Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
- Median Technologies — We harness the power of Imaging Phenomics to contribute to the development of next generation treatments and care strategies for patients in need.
A pioneer in private equity in France, LBO France is now a leading multi-specialist, multi-country investment platform.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Series B
- Geography: France, Spain, Germany
Investor stats
- Total investments: 36
- Round size: Series A $3.3M–$18M; Series B $16M–$191M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $181M in 2021
Portfolio highlights
- Toothfairy — Winner of app of the year, for emergencies, teeth straightening, teeth whitening & prescriptions. Teledentistry and dentist available 24/7. Founded by dentists.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more...Investment focus
- Industry: Energy, Health Care, Software
- Stage:Debt Financing, Seed
- Geography: France, United States, Italy
Investor stats
- Total investments: 149
- Round size: Seed $768k–$4.4M; Debt Financing $8.8M–$1.3B
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Crelan — Crelan is a co-operative bank that offers a wide range of banking and insurance products to individuals and entrepreneurs.
- FlowPay — Open banking & payment solutions. FlowPay supporta la tua azienda nei flussi di incasso e pagamento con soluzioni innovative integrabili via API.
- Justclip — Justclip is a French company that offers DIY electrical installation kits designed to make electrical work accessible to everyone, even those without technical skills or experience in electricity. The system is based on a modular, clip-together design—components can be easily connected from an existing power source (such as a wall socket, solarpanel, or battery) without the need for specialized tools or professional assistance.
Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed
- Geography: France, Spain, Ecuador
Investor stats
- Total investments: 25
- Round size: Seed $1.1M–$24M; Series A $7.7M–$44M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
- RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Industry: Health Care, Software, Food and Beverage
- Stage:Seed, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 109
- Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
- MilkStraw AI — Saving companies up to 75% on AWS
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 52
- Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
- DiappyMed — DiappyMed specializes in developing platforms to calculate insulin dosages.
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 140
- Round size: Seed $2M–$10M; Series A $3.8M–$25M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- DESKi — HeartFocus is an AI-powered heart exam software for ultrasound and can be used with any hand-held probe, cart or ultrasound system. The product is available as an APP or SDK and is appropriate for clinics, health systems and learning institutions
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Series B, Series A
- Geography: France
Investor stats
- Total investments: 16
- Round size: Series A $5.7M–$74M; Series B $9.9M–$80M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 214
- Round size: Seed $1.1M–$9.9M; Series A $2.2M–$26M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Elevo — Elevo is a Paris-based performance management platform.
- Vibe — Advertise your brand on CTV & OTT content with Vibe's self-serve ad platform to target hundreds of channels & networks and reach millions of households.
- Traefik Labs — Cloud-native, GitOps-driven API runtime solutions for demanding DevOps and Platform Engineers with diverse use-cases, environments, and deployment models.
Isai is a tech entrepreneurs' fund that focuses on early-stage internet startups and small capital tech private equity deals. It seeks to invest in companies operating in the software, information technology, media, and industrial sectors. It brings together more than 300 tech entrepreneurs who have decided to invest their money and theirexperience in order to allow the emergence of new French Tech champions.Founded in 2010, Isai is headquartered in Paris, France.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Series A, Seed, Series B
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 165
- Round size: Seed $878k–$8M; Series A $2.2M–$22M; Series B $5.6M–$50M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $196M in 2024
Portfolio highlights
- FinFrog — FinFrog accompagne les particuliers dans la gestion de leur budget en leur proposant des micro-prêts faciles d’accès. FinFrog propose un crédit 100% sur mobile avec une demande de prêt qui ne prend pas plus de 5 minutes. FinFrog encourage un recours responsable à l’emprunt, avec des critères d'octroi stricts et adaptés aux changements de lasociété. Retrouvez-nous sur https://www.finfrog.fr et sur https://www.finfrog.blog
- Pricemoov — Pricemoov is a global provider of next-generation price management and optimization solutions that help companies power digital commerce, adapt to market dynamics, and empower sales teams. Featuring powerful data science, end-to-end automation, and an intuitive user experience, the cloud-native Pricemoov platform enables B2B and B2C businesses to unlock their revenue potential with intelligent pricing.
- Inicio — Inicio's objective is to expedite the energy transition of territories by lowering the risk of establishing solar projects and encouraging collaborations between landowners and renewable energy project developers.
ODYSSEE VENTURE is a French Venture Capital and Private Equity firm. It was founded by Mathieu Boillet and Sébastien Sassolas in 1999 and is based in Paris, France. The company has raised over 600M€.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Series A, Private Equity
- Geography: France, United States
Investor stats
- Total investments: 84
- Round size: Series A $1.6M–$11M; Private Equity $2.2M–$2.3M
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Veesion — Veesion: AI-driven smart video surveillance. Detect theft in real time. Protect your business now.
- Terratis — Terratis is a French company that uses the Sterile Insect Technique (SIT) to reduce the populations of tiger mosquitoes and agricultural pests. Their mission is to diminish harmful insect populations effectively on a large scale using a scientific, innovative, ecological, and efficient approach.
- BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Extens believes that the healthcare industry is undergoing profound transformation and that information and communication technologies (ICTs) will gradually bring about, and today, considerable improvements. E-health will contribute to the transformation of health pathways by improving the performance of care, allowing a better quality of life atall stages of life and reducing the inefficiencies of our health systems.
Show more...Investment focus
- Industry: Medical, Health Care, Apps
- Stage:Private Equity
- Geography: France
Investor stats
- Total investments: 6
- Lead/follow: 67% lead, 33% follow
- Last fund: Likely still investing — raised $124M in 2022
Portfolio highlights
- Kayentis — Since 2005, Kayentis has supported pharma, biotechs, and CROs by capturing meaningful patient input. With user-friendly eCOA technology and top-quality services, we ensure high quality datasets and improve the experiences of patients and sites. Challenge your eCOA vendor and embark on a seamless eCOA clinical trial experience with us!
- Keenturtle — Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data.
- DigitecPharma — DigitecPharma is a SaaS powered mobile application platform for patient relationship management for pharmaceutical dispensaries.
Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 38
- Round size: Seed $505k–$3.4M; Series A $549k–$12M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Pikkopay — Pikkopay provides a mobile payment solution that transforms customer smartphones into cash registers. Customers can scan items, pay, and go, eliminating the need for traditional checkout lines. The service aims to streamline the shopping experience and increase user retention rates. Pikkopay is designed to save time for both customers andretailers, offering a hassle-free shopping experience.
- StemInov — StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC).
- Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 544
- Round size: Seed $549k–$5.5M; Pre-Seed $584k–$4.4M; Series A $1.1M–$16M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Hoora —
- Avocode — Centralize design collaboration, developer hand-off, version control, screen flows, & feedback in one tool. Sign up free today. Work with Sketch, Adobe XD, Photoshop, Illustrator, and Figma designs on macOS, Windows, and Linux.
- Flow Engineering — Requirements management, made collaborative
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 18
- Round size: Seed $549k–$2.7M; Series A $7.5M–$7.7M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $42M in 2014
Portfolio highlights
- PeptiMimesis — PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors.PeptiMimesis will develop its pipeline against keytargets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
- Inoviem Scientific — Our groundbreaking label-free technologies enable you to detect and identify the clinical power of, and weaknesses in, your compound from early-stage pre-clinical R&D through to clinical trials
- Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
French VC fund insanely focused on bringing massive strategic and operational support to its entrepreneurs.
Show more...Investment focus
- Industry: SaaS, Rental, Internet
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 25
- Round size: Seed $329k–$2.2M; Series A $3.3M–$11M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Lokki — Lokki is a software tool for equipment rental companies.
- Skillup — Skillup has designed the new @Tripadvisor for professional trainings hosting over 20k trainings and 50k reviews. It aims at helping HR services to find the adequate trainig for employees.
- Napta — PickYourSkills is a SaaS solution helping companies to find the best match between their projects and their employees.
Région Sud Investissement is an investment Firm.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: France, Spain
Investor stats
- Total investments: 60
- Round size: Seed $1.1M–$5.8M; Series A $2.2M–$22M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Agriodor — Agriodor is to provide concrete and effective alternatives to insecticides to help farmers produce more sustainably.
- K-Motors — K-Motors develops modules that improve the battery cycle of electric vehicles and motors.
- MYCOPHYTO — Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection.
IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: France
Investor stats
- Total investments: 44
- Round size: Seed $1.9M–$9.2M; Series A $1.6M–$22M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
- Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Banque des Territoires is a Investment Firm.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 101
- Round size: Seed $1.4M–$7.8M; Series A $3.7M–$31M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Kapsera — Kapsera bridges the gap between sustainability and productivity in agriculture, using cutting-edge, biosourced and biodegradable formulation technologies.Kapsera offers natural and innovative formulations for microbials based biofertilizers and biopesticides.
- Worldia — Worldia is an online travel agency.
- AdEchoTech — The company was the first to market a robotic tele-ultrasound solution, expanding the capabilities currently offered in the field of teleradiology.
Innovacom provides new technologies, hardware, and software products. They focus on the creation of financial and strategic value through support, networking, and the search for the best industrial partners for our startups in a context of open innovation.
Show more...Investment focus
- Industry: Software, Mobile, Telecommunications
- Stage:Series A, Series B
- Geography: France, United States, Canada
Investor stats
- Total investments: 151
- Round size: Series A $2.4M–$13M; Series B $3M–$58M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- Nexess — Nexess SAS develops and sells security management solutions for nuclear and Seveso-type plants. It offers NexLink, a software platform for security and productivity; identification products, such as personal security badges, RFID tags, optical tags, high temperature RFID tags, touch based self service counters, mobile devices, rugged mobilesystems, NexLink display screens, and smart cabinets; smart camera systems that offers autonomous image analysis and real time data transmission; and RFID antenna systems, which allows objects detection and surveillance in harsh environments. The company offers its products for applications, such as hazardous products traceability, smart automatic secured cabinets to manage equipments, site localization equipments and operation securing, and hazardous zone access detection. Nexess SAS was founded in 2006 and is based in Mougins, France with an additional office in Paris, France.
- Tilkal — Tilkal is the software infrastructure building traceability and transparency for industrial sectors. Combining private blockchain networks and big data, Tilkal organizes an end-to-end, real-time traceability across supply chains for greater control, security and transparency.
- Avicenna.ai — Discover how Avicenna.AI, a globally certified company, is revolutionizing emergency care with AI tools for radiology. Learn what radiologists think about Avicenna.AI and explore our latest news on AI-powered solutions that detect critical CT findings seamlessly integrated into PACS. Join us in advancing healthcare with cutting-edge technology!
Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 35
- Round size: Seed $329k–$2.6M; Series A $1.1M–$25M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
- Hemerion — Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
- Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: France, United States, Canada
Investor stats
- Total investments: 91
- Round size: Series A $3.3M–$27M; Series B $6.7M–$43M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- STIMIO — Anticipation de pannes, priorisation d'actions de maintenance, optimisation de l'exploitation avec les solutions IoT de Stimio.
- NEOBRAIN — Neobrain offers transformation support platforms that meet three needs within organisations: employee commitment and loyalty; simplification and fluidity of mobility; alignment of employee skills with the company's strategy.
- Quandela — Discover Quandela's revolutionary photonic quantum computers and cloud platform, trusted by 950+ users worldwide. From hardware to software, we deliver scalable quantum solutions for energy, finance, and cybersecurity challenges. Experience the future of computing today.
Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Seed, Private Equity
- Geography: France
Investor stats
- Total investments: 51
- Round size: Seed $341k–$2.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- vebo — Vebo is a French company offering a removable electric motor kit that instantly transforms standard bicycles into electric bikes by quickly attaching the motor to the front wheel. The system is designed for versatility and ease of use, allowing one Vebo motor to be shared among multiple bikes simply by installing a supplemental bracket on each
- CGREEN — CGREEN is developing a biosourced, low-carbon carbon fiber derived from cellulose — a renewable, local, and abundant resource.
- Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.
Show more...Investment focus
- Industry: Medical Device, Artificial Intelligence, Drones
- Stage:Series A, Series B
- Geography: France
Investor stats
- Total investments: 14
- Round size: Series A $7.7M–$15M; Series B $15M–$39M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $105M in 2018
Portfolio highlights
- BrainEver — BrainEver is developing a portfolio of drug candidates focused on major neurodegenerative diseases with significant unmet medical needs: ALS, Parkinson, and
- Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Turenne Capital is an independant private equity management company, with 4 offices in France : - Paris - Lyon - Marseilles - Lille (joint-venture). Since 1999, Turenne Capital has been taking significant minority or majority equity stakes alongside entrepreneurs who operate SMEs with revenues ranging from €5 million to € 100 million. Itinvests between €1 million and €10 million per transaction. Turenne Capital manages/advises more than € 500 million. 32 people, among which 21 investors work in the Group. ------------------------------------------------------------------------------ Turenne Capital est une Société de gestion indépendante spécialisée en capital investissement. Turenne Capital accompagne depuis 1999 des entrepreneurs dans leur développement et la transmission de leur société et est implantée à : - Paris - Lyon - Marseille - Lille (filiale) Les tickets d'investissement vont de '1 à 10 millions d'euros en minoritaire et majoritaire dans des PME de 5 à 100 M€ de Chiffre d'affaires. Le Groupe Turenne Capital compte 32 professionnels dont 21 investisseurs, et gère/conseille plus de 500 M€ confiés par des institutionnels et des particuliers.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Series A, Private Equity
- Geography: France, Poland, Germany
Investor stats
- Total investments: 51
- Round size: Series A $2.8M–$22M; Private Equity $3.3M–$11M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
- AlgoTherapeutix — AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Belgium, France, Spain
Investor stats
- Total investments: 39
- Lead/follow: no public data
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Bpifrance Digital Venture operates as a venture capital firm.
Show more...Investment focus
- Industry: Health Care, SaaS, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: France, India
Investor stats
- Total investments: 23
- Round size: Seed $3.5M–$10M; Pre-Seed $439k–$1.9M; Series A $3.1M–$17M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Edflex — Edflex est une solution SaaS qui connecte les entreprises avec les meilleurs contenus de formation (MOOC, vidéos, podcasts, articles…).
- Firecell — Firecell is a Telecommunications Industry.
- altrove AI — Altrove - Sustainable Alternatives to Critical Materials
On-the-ground expert investors in early-stage digital. Ready to meet you, wherever you are.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: France, Germany, United States
Investor stats
- Total investments: 190
- Round size: Seed $1.2M–$5.8M; Series A $3.8M–$18M; Series B $5.6M–$69M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Crobox — Crobox's next generation guided selling solution humanizes your product data and discovery experience with product finders and product data enrichment.
- Antidot — Antidot is a software vendor that leverages 20 years of advanced research in semantic search and content enrichment to develop its content delivery platform (CDP). The company’s products multiply the value of content by delivering dynamic information in a personalized and contextualized form. Antidot helps more than 150 customers around the worldimprove their operational efficiency.
- Custom Surgical — Custom Surgical is democratizing hardware and software to record microscope procedures easily and quickly without any professional engineer to attach or cables to share live.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 158
- Lead/follow: no public data
Portfolio highlights
- Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
- Raidium — Radiology augmented GPT to tackle the complexity of precision medicine
- Arenametrix — Arenametrix is the first Customer Data Platform dedicated to entertainment.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $21M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Private Equity, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 64
- Round size: Series A $2.2M–$13M; Private Equity $3.3M–$22M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $70M in 2020
Portfolio highlights
- Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
- Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
- Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Rhone-Alpes Creation is a venture capital firm that focuses on early-stage investments in software and biotechnology.
Show more...Investment focus
- Industry: Environmental Engineering, Mobile, Medical
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 19
- Round size: Seed $878k–$3.9M; Series A $1.4M–$4.4M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
- CentrExpert — CentrExpert provides global safety solutions for training, material audit transformation of standard industrial equipment to make it usable in areas with certification and after-sales service. The company is committed to converting machines and equipment, enabling it to be used in explosive atmospheres, more commonly known as ATEX zones.CentrExpert was founded on 2011 and is headquartered in Chasse-sur-rhône, France.
- APIX Analytics — APIX Analytics is a nano-silicon based chemical analysis for industrial, environmental, and security applications. The company focuses on the development of miniaturized multigas analyzers systems based on integration on silicon of analytical chains such as sampling, injection of gases, separation of complex gas mixtures to improve specificity anddetection, identification, and quantification of each mixture compound.APIX Analytics was founded on 2014 and is headquartered in Grenoble, France.
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B
- Geography: France, Germany, United States
Investor stats
- Total investments: 180
- Round size: Series A $3.5M–$44M; Series B $4.4M–$43M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $403M in 2020
Portfolio highlights
- SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- Capsule Labs — We create frictionless web3 solutions for widespread adoption / Capsule Corp Labs
we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical Device
- Stage:Series A, Series B
- Geography: France, Switzerland, United States
Investor stats
- Total investments: 100
- Round size: Series A $6M–$30M; Series B $7.7M–$65M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Quobly — Quobly create and market a universal large-scale quantum computer, using tried-and-true semiconductor industry procedures.
- SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
- Wise Integration — Wise Integration is a developer of GaN-integrated solutions to miniaturize power supplies and improve energy efficiency.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Equity Crowdfunding
- Geography: France, Norway
Investor stats
- Total investments: 30
- Round size: Seed $384k–$3.3M; Equity Crowdfunding $466k–$2.7M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Semiconductor
- Stage:Seed, Series A
- Geography: France, Canada, United States
Investor stats
- Total investments: 45
- Round size: Seed $796k–$21M; Series A $1.4M–$13M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- iNGage — iNGage is a manufacturer of high-performance inertial MEMS navigation sensors for high-volume autonomous mobility markets
- STELLARIA — Stellaria is a 200 MWe molten salt reactor with 20-year autonomy, delivering safe, sustainable nuclear power without refueling.
- STELLARIA — Stellaria is reimagining sustainable rapid neutron nuclear energy.
Serena is one of Europe's leading venture capital funds, with $750m under management. Founded in 2008, Serena invests at early stages, from seed to series B, and supports the success of innovative and ambitious entrepreneurs to service a better world. Born of the profound conviction that a venture capital fund should be at the service of itsportfolio companies, Serena has set up the largest operational support team in Europe and the most active startup community, the Serena Squad, with more than 550 active C-levels. Serena has a strong focus on AI, SaaS, Climate Tech, Digital Transformation, and Impact. Serena has invested in more than 100 startups with several international success stories such as Dataiku, Malt, The Fork, Electra, Descartes Underwriting, Accenta, Lifen, and AramisAuto. Combating climate change, protecting biodiversity, promoting sustainability, diversity and inclusion are at the heart of Serena's DNA.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Series A, Seed, Series B
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 159
- Round size: Seed $1.4M–$15M; Series A $3.3M–$20M; Series B $6.6M–$55M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Inato — Inato matches the right sites to the right clinical research study, globally.
- iContainers — Instant freight rates with leading cargo freight forwarders offering top freight forwarding services. Get the best freight shipping rate & quotes in just a few clicks!
- Descartes Underwriting — Descartes Underwriting is an insurtech company that specializes in climate risk modeling and data-driven risk transfer. It works with corporate brokers to design and underwrite innovative, bespoke, and affordable insurance. The company offers tech-based insurance products covering risks such as flooding, wildfires, droughts, and other large-scaleevents to businesses, across all sectors, including agriculture, hospitality, mining, construction, traditional and renewable energy, entertainment, and retail. The company was founded in 2019 and is headquartered in Puteaux, Ile-de-France, France.
Medical VC funding in France at a glance
Stats across 515 deals from 556 investors.
Access all 556 VC funds in France Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 556 VC funds investing in France Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!